EDESA BIOTECH, INC. Cost of Goods Sold (Deprecated 2018-01-31)
EDESA BIOTECH, INC. (EDSA) reported Cost of Goods Sold (Deprecated 2018-01-31) of $2.80 thousand for the 3-month period ending 2017-12-31, per its 10-Q filed 2018-02-07.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsSold · last filed 2018-02-07
- EDESA BIOTECH, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $2.80K, a 96.43% decline year-over-year.
- EDESA BIOTECH, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2016-12-31 was $78.56K.
- EDESA BIOTECH, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2015-06-30 was $251.00K, a 69.70% increase year-over-year.
- EDESA BIOTECH, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2015-03-31 was $250.24K, a 69.10% increase year-over-year.
- EDESA BIOTECH, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2014 was $662.95K, a 261.72% increase from fiscal 2013.
- EDESA BIOTECH, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2013 was $183.28K, a 57.01% decline from fiscal 2012.
- EDESA BIOTECH, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2012 was $426.31K.
| Period end | Cost of Goods Sold (Deprecated 2018-01-31) 1 month | Cost of Goods Sold (Deprecated 2018-01-31) 3 month | Cost of Goods Sold (Deprecated 2018-01-31) 6 month | Cost of Goods Sold (Deprecated 2018-01-31) 9 month | Cost of Goods Sold (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|---|
| 2017-12-31 | $2.80K 10-Q · filed 2018-02-07 | ||||
| 2016-12-31 | $78.56K 10-Q · filed 2018-02-07 | ||||
| 2015-06-30 | $251.00K 10-Q · filed 2015-08-10 | $501.24K derived: sum of 2 quarters · filed 2015-08-10 | $661.64K 10-Q · filed 2015-08-10 | ||
| 2015-03-31 | $250.24K 10-Q · filed 2015-05-11 | $410.64K 10-Q · filed 2015-05-11 | |||
| 2014-12-31 | $160.40K 10-Q · filed 2015-02-09 | ||||
| 2014-09-30 | $22.59K 10-Q · filed 2015-02-09 | ||||
| 2014-08-31 | $662.95K 10-K · filed 2014-11-21 | ||||
| 2014-06-30 | $147.91K 10-Q · filed 2015-08-10 | $295.89K derived: sum of 2 quarters · filed 2015-08-10 | $442.82K 10-Q · filed 2015-08-10 | ||
| 2014-03-31 | $147.98K 10-Q · filed 2015-05-11 | $294.91K 10-Q · filed 2015-05-11 | |||
| 2013-12-31 | $146.93K 10-Q · filed 2015-02-09 | ||||
| 2013-08-31 | $183.28K 10-K · filed 2014-11-21 | ||||
| 2012-08-31 | $426.31K 10-K · filed 2014-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |